Related Experiment Video
Updated: Jul 19, 2026

11:20
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
3.0K
Severe primary graft failure: Are there lasting impacts? Analysis from the PHTS Database
Jennifer Conway1, Tara Pidborochynski2, James K Kirklin3
1Stollery Children's Hospital, Edmonton, Alberta, Canada.
JHLT Open
|March 27, 2025
Summary
Primary graft failure (PGF) after heart transplantation (HTx) predicts early mortality but not long-term outcomes. Further research is needed to understand the impact of milder PGF on survival and long-term results.
Area of Science:
- Cardiovascular Surgery
- Transplantation Immunology
- Pediatric Cardiology
Background:
- Primary graft failure (PGF) is a major cause of early morbidity and mortality following heart transplantation (HTx).
- PGF arises from graft ischemia and subsequent ischemia-reperfusion injuries to the donor heart's cardiomyocytes and vasculature.
- Longer-term outcomes for patients experiencing PGF after HTx remain understudied.
Purpose of the Study:
- To investigate the long-term outcomes and survival rates of patients who experience primary graft failure (PGF) after heart transplantation (HTx).
- To identify predictors of PGF and its impact on graft survival, rejection, and coronary allograft vasculopathy (CAV).
Main Methods:
- Retrospective analysis of 4,982 patients undergoing primary HTx between January 1, 2010, and June 30, 2022, using the Pediatric Heart Transplant Society registry.
- PGF defined as death, retransplantation, or need for mechanical circulatory support within 72 hours of HTx.
- Kaplan-Meier analysis and Cox proportional hazard modeling were employed to assess survival and risk factors.
Main Results:
- 5.4% of patients (n=269) experienced PGF, characterized by younger age, higher prevalence of congenital heart disease, longer bypass and ischemic times, and increased pre-transplant support.
- PGF was associated with significantly lower overall survival at 1 year (54% vs. 94%) and predicted early graft loss and conditional survival up to 90 days.
- No significant differences in freedom from rejection or coronary allograft vasculopathy (CAV) were observed between PGF and non-PGF groups beyond 90 days.
Conclusions:
- Severe PGF independently predicts early mortality post-HTx but does not adversely affect long-term survival, rejection rates, or CAV.
- Further investigation into the impact of milder forms of PGF on patient outcomes is warranted.
- Developing strategies to mitigate PGF risk, such as improved preservation techniques, may reduce early post-HTx mortality.
Related Concept Videos
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

